GLI1 and carcinoma: The immunohistochemical expression levels of SHH, DHH, PTCH, SMO, and GLI1 proteins in ovarian tumors correlated strongly with malignant features, being higher in carcinomas than in borderline malignant tumors and, to a lesser extent, in benign cystadenomas.